Profil Tempus AI rStock (RTEM)

Tempus AI, Inc. develops artificial intelligence applications and genomic sequencing pipelines engineered for precision medicine and clinical oncology data aggregation. By constructing an extensive database of de-identified clinical records mapped directly to next-generation genomic sequencing (NGS), the firm monetizes via diagnostic sequencing fees for hospitals and high-value healthcare data analytics licensing for global pharmaceutical R&D labs.